The goal of this clinical trial is to test whether an accelerated deep Transcranial Magnetic Stimulation (dTMS) protocol in combination with cognitive training can improve cognitive abilities in older adults with Subjective Cognitive Decline (SCD) or Mild Cognitive Impairment (MCI). The study will look at whether it is safe and tolerable to use accelerated dTMS to enhance the benefits of cognitive training in older adults, and will also gather early information on the effects of accelerated dTMS on memory and other cognitive abilities.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Percentage of dTMS sessions attended by participants
Timeframe: 1 week
Incidence and type of of adverse events experienced during treatment (participant-reported tolerability) based on the Adverse Events Questionnaire (AEQ)
Timeframe: 9 weeks
The number of participants who prematurely withdraw and reasons for withdrawal
Timeframe: 9 weeks
Change from baseline memory scores on computerized neuropsychological battery following the final session on day 5
Timeframe: 9 weeks
Change from baseline executive function scores on computerized neuropsychological battery following final session on day 5
Timeframe: 9 weeks